Need a specific person's email?
Browse Nammi Therapeutics, Inc.'s employee directory (about 9 employees) and reveal verified emails free.
Nammi Therapeutics, Inc.'s most common email format is First.Last@nammirx.com (ex. John.Doe@nammirx.com), used for 100% of nammirx.com addresses. Nammi Therapeutics, Inc. uses 1 email pattern.
| Format | Example | Share of nammirx.com |
|---|---|---|
| First.Last@nammirx.comMost common | John.Doe@nammirx.com |
Browse Nammi Therapeutics, Inc.'s employee directory (about 9 employees) and reveal verified emails free.
Biotechnology ResearchCalifornia, United States2-10 Employees
Nammi Therapeutics, Inc. is a biotechnology company in the immuno-oncology field focusing on activating anti-tumor immunity within the tumor microenvironment while minimizing systemic immune activation. This approach is intended to improve safety and enable the combination of multiple immune modulators. Its lead candidate, QXL138AM, is a masked immunocytokine designed to deliver an interferon signal to the tumor antigen CD138; the company has also developed a nanoparticle delivery approach, Nammisome, with several candidates in development. Nammi is based in Los Angeles, California, and operates with a small team serving the oncology research and development ecosystem through platform-based approaches. In August 2024, it disclosed plans to begin a first-in-human Phase 1 study for QXL138AM.
Most common format
First.Last@nammirx.com
Example: John.Doe@nammirx.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.